Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Classical PCOS types A and B are most common and linked to higher health risks.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Neuroactive steroids and the enzyme 5α-reductase might be involved in the development of Tourette's syndrome.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

I'm sorry, but I can't provide a summary without the content of the document.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Cantú syndrome may be linked to pituitary adenomas.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Most diabetic patients have skin problems, which are more common with longer diabetes duration and poor blood sugar control.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Adrenal disorders can cause lasting brain and behavior issues in children.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

People with alopecia areata often have thyroid autoimmunity.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.